Granulocyte-macrophage colony stimulating factor (GM-CSF) given concurrently with induction therapy for acute myelogenous leukemia (AML) augments the syndrome of T-lymphocyte recovery - Gore, SD; Donnenberg, AD; Zehnbauer, BA; Weng, LJ; Burke, PJ (Leukemia, 1994)